NU17CE010198
Cooperative Agreement
Overview
Grant Description
Addressing rising overdose rates through data surveillance and intentional action - Maine has the 9th highest age-adjusted death rate due to fatal overdose in the nation and 1st amongst New England states. Rates of self-reported 30-day illicit substance use is higher in Maine than regional and national averages.
The Maine Office of Behavioral Health is ideally situated to address these continued issues. Office of Behavioral Health (OBH) is the single state agency (SSA) for both mental health and substance use disorder, and the state opioid treatment authority (SOTA) for Maine. OBH is a leader and an active partner in Maine’s efforts to ensure timely access to a comprehensive continuum of behavioral health services around the state.
The activities selected for this project will rapidly inform appropriate interventions to drug overdoses with high quality and timely data to reduce the overall harm from drug use, with a focus on surveillance and prevention strategies.
Surveillance related strategies include maintaining and enhancing timely access to data related to drug-related harms and the effective utilization of data to address drug-related harms. Outcomes for surveillance activities include: increased timely, detailed, comprehensive, and actionable surveillance data, including toxicology testing for both nonfatal and fatal overdose cases (Activities 2.1, 7:1, 7:2, Strategy 3); increased data dissemination (Activities 1.1, 1.2); increased identification of factors contributing to overdose using linked data sets (Activities 1.2, 1.2, 2.1, 2.2, Strategy 3); increased data sharing and data availability (Activities 1.2, 2.2, 6:4, 7:1, 7:2).
The project also includes an emphasis on strategies focused on leveraging partnerships and data-informed programming to prevent drug-related harms. Outcomes for prevention activities include: increased clinician awareness of evidence-based practices for pain management (Activity 6:1); increased clinician expertise and confidence to provide equitable opioid use disorder (OUD) and stimulant use disorder (SUD) care (Activity 6:2); increased collaboration, coordination, and communication among partners; increased use of navigators to link people who use drugs to care and services (Activities 6:3, 8.1, 8.2, 9.1); increased access to harm reduction education and services, including increased distribution of naloxone (Activity 8.2).
These activities build on existing evidence-based programming to deepen their potential impact and reach. The project maintains a focus on populations that experience a disparate degree of drug-related harms. This is integrated into strategy selection and part of the project's quality impact plan, that is intended to observe and adapt strategies and activities as needed to enhance engagement by and address barriers to services and specific factors that contribute to disparities.
The Maine Office of Behavioral Health is ideally situated to address these continued issues. Office of Behavioral Health (OBH) is the single state agency (SSA) for both mental health and substance use disorder, and the state opioid treatment authority (SOTA) for Maine. OBH is a leader and an active partner in Maine’s efforts to ensure timely access to a comprehensive continuum of behavioral health services around the state.
The activities selected for this project will rapidly inform appropriate interventions to drug overdoses with high quality and timely data to reduce the overall harm from drug use, with a focus on surveillance and prevention strategies.
Surveillance related strategies include maintaining and enhancing timely access to data related to drug-related harms and the effective utilization of data to address drug-related harms. Outcomes for surveillance activities include: increased timely, detailed, comprehensive, and actionable surveillance data, including toxicology testing for both nonfatal and fatal overdose cases (Activities 2.1, 7:1, 7:2, Strategy 3); increased data dissemination (Activities 1.1, 1.2); increased identification of factors contributing to overdose using linked data sets (Activities 1.2, 1.2, 2.1, 2.2, Strategy 3); increased data sharing and data availability (Activities 1.2, 2.2, 6:4, 7:1, 7:2).
The project also includes an emphasis on strategies focused on leveraging partnerships and data-informed programming to prevent drug-related harms. Outcomes for prevention activities include: increased clinician awareness of evidence-based practices for pain management (Activity 6:1); increased clinician expertise and confidence to provide equitable opioid use disorder (OUD) and stimulant use disorder (SUD) care (Activity 6:2); increased collaboration, coordination, and communication among partners; increased use of navigators to link people who use drugs to care and services (Activities 6:3, 8.1, 8.2, 9.1); increased access to harm reduction education and services, including increased distribution of naloxone (Activity 8.2).
These activities build on existing evidence-based programming to deepen their potential impact and reach. The project maintains a focus on populations that experience a disparate degree of drug-related harms. This is integrated into strategy selection and part of the project's quality impact plan, that is intended to observe and adapt strategies and activities as needed to enhance engagement by and address barriers to services and specific factors that contribute to disparities.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Maine
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 100% from $2,920,497 to $5,840,994.
Maine Department Of Health And Human Services was awarded
Maine Data Surveillance Grant: Addressing Rising Overdose Rates
Cooperative Agreement NU17CE010198
worth $5,840,994
from Injury Center in September 2023 with work to be completed primarily in Maine United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.136 Injury Prevention and Control Research and State and Community Based Programs.
The Cooperative Agreement was awarded through grant opportunity Overdose Data to Action in States.
Status
(Ongoing)
Last Modified 5/20/25
Period of Performance
9/1/23
Start Date
8/31/28
End Date
Funding Split
$5.8M
Federal Obligation
$0.0
Non-Federal Obligation
$5.8M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU17CE010198
Transaction History
Modifications to NU17CE010198
Additional Detail
Award ID FAIN
NU17CE010198
SAI Number
NU17CE010198-1971537454
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CUH0 CDC NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL
Awardee UEI
GJEPWTMKF5A3
Awardee CAGE
43CF9
Performance District
ME-90
Senators
Susan Collins
Angus King
Angus King
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Injury Prevention and Control, Centers for Disease Control and Prevention, Health and Human Services (075-0952) | Health care services | Grants, subsidies, and contributions (41.0) | $2,920,497 | 100% |
Modified: 5/20/25